Page last updated: 2024-09-05

dabigatran and Diabetic Angiopathies

dabigatran has been researched along with Diabetic Angiopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fukuda, D; Kusunose, K; Rahadian, A; Salim, HM; Sata, M; Shimabukuro, M; Soeki, T; Yagi, S; Yamada, H	1

Other Studies

1 other study(ies) available for dabigatran and Diabetic Angiopathies

Article	Year
Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice. Vascular pharmacology, 2020, Volume: 124 Topics: Animals; Antithrombins; Cells, Cultured; Dabigatran; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Inflammation Mediators; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phosphorylation; Receptors, Proteinase-Activated	2020

Article

Year

Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice.

Vascular pharmacology, 2020, Volume: 124

Topics: Animals; Antithrombins; Cells, Cultured; Dabigatran; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Inflammation Mediators; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phosphorylation; Receptors, Proteinase-Activated

2020